A Study to Evaluate the Safety and Efficacy of NT-88
NCT07509801
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Heart Failure With Mildly Reduced Ejection Fraction
Interventions
DRUG:
Conventional therapeutic drugs
DRUG:
NT-88
Sponsor
Guangzhou Manjing biomedicine technology co., ltd